Cobamamide liposomal - HanAll BioPharma

Drug Profile

Cobamamide liposomal - HanAll BioPharma

Alternative Names: ADC liposomal gel; Adenosyl-B12 liposomal gel; Adenosylcobamide liposomal gel - HanAll BioPharma; Cobamide; HL-009; Liposomal adenosylcobalamin (vitamin B12) - HanAll Biopharma

Latest Information Update: 26 Jun 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator HanAll Biopharma; Korea Research Institute of Chemical Technology
  • Developer HanAll Biopharma
  • Class Vitamin B12 analogues
  • Mechanism of Action Nitric oxide inhibitors; Nitric oxide synthase inhibitors; Regulatory T-lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Atopic dermatitis

Most Recent Events

  • 26 Jun 2015 Phase II development is ongoing in the USA and South Korea
  • 01 Aug 2013 HanAll BioPharma completes a phase II trial in Atopic dermatitis in USA (NCT01568489)
  • 20 Apr 2012 HanAll BioPharma plans a phase III trial for Atopic dermatitis in South Korea
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top